Holy moly. This is absolutely brilliant news @RBx! I didn't expect this so soon, after the whole "tumour" ridiculousness.
So this patent covers DARRT, at least for prostate cancer, it seems. We'll probably see continuations/divisionals for the other types of cancer they are including into DARRT-2 (and this may partly explain this expansion of DARRT-2 into other cancer types?), and any protocol changes that emerge.
In any case, intellectual property is now a non-issue for NOX. With various coverages in AU, EU, JP and now the US, it is basically a tickbox exercise for the patent lawyers to fill in the gaps.
I expect it will be a HUGE week for NOX next week. I'm off to have a drink to celebrate. Have a great weekend folks and congratulations to Noxopharm!
Radiotherapy Improvements ALLOWED, page-2
Add NOX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.4¢ |
Change
0.009(12.0%) |
Mkt cap ! $24.54M | |||
| Open | High | Low | Value | Volume |
| 8.0¢ | 8.8¢ | 8.0¢ | $41.98K | 504.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 50000 | 7.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.9¢ | 91029 | 2 |
View Market Depth
| Last trade - 16.10pm 28/05/2024 (20 minute delay) ? |
|
|||||
|
Last
8.3¢ |
Change
0.009 ( 13.7 %) |
||||
| Open | High | Low | Volume | ||
| 7.9¢ | 8.3¢ | 7.9¢ | 76848 | ||
| Last updated 13.50pm 28/05/2024 ? | |||||
| NOX (ASX) Chart |